2017
DOI: 10.1039/c6md00383d
|View full text |Cite|
|
Sign up to set email alerts
|

Boron-containing delocalised lipophilic cations for the selective targeting of cancer cells

Abstract: To limit the incidence of relapse, cancer treatments must not promote the emergence of drug resistance in tumour and cancer stem cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 45 publications
0
6
0
Order By: Relevance
“…10 B-drugs to tumour cells is followed by irradiation with slow neutrons ( 1 n), leading to tissue repair. (Adapted from Calabrese et al [20]).…”
Section: Boron Neutron Capture Therapymentioning
confidence: 99%
See 2 more Smart Citations
“…10 B-drugs to tumour cells is followed by irradiation with slow neutrons ( 1 n), leading to tissue repair. (Adapted from Calabrese et al [20]).…”
Section: Boron Neutron Capture Therapymentioning
confidence: 99%
“…The first step is the selective uptake of a therapeutic dose of the drug by the cancer cells; this is critical for the success of the BNCT treatment. The second step involves irradiating the area of interest with a neutron beam to form 11B, which undergoes nuclear fission, releasing the radiating energy that leads to a high probability of local tumour cell death by direct DNA damage [20]. Accordingly, the nuclear reaction of 10 B can be used for the selective destruction of malignant tumour cells without compromising nearby normal and healthy tissues [21].…”
Section: Boron Neutron Capture Therapymentioning
confidence: 99%
See 1 more Smart Citation
“…Many other targeting sites have been explored, often focusing on cancer therapies and receptors overexpressed on malignant cells . Promising new ligands are identified regularly, and their discussion goes well beyond the scope of this review (see Table , highlighted in green).…”
Section: Active Targetingmentioning
confidence: 99%
“…Nevertheless, relevant structure‐related properties such as subcellular biodistribution and dynamic of fluorescent‐derived carboranes are still an unmet need. To move towards this goal, several chemical architectures containing carborane fragments have been synthetized by our group, [14] however their molecular structures cannot be easily related to their subcellular distribution and function, even though some correlation of general physicochemical observables has been reported to be helpful on achieving specific biological properties for a great variety of compounds [1b, 10d, 15] …”
Section: Introductionmentioning
confidence: 99%